Last reviewed · How we verify
NCT03971682: PSYCOMP
The Efficacy of a Compassion Focused Therapy-based Intervention in Detained Youth
NA trial testing PSYCHOPATHY.COMP program. in Psychopathic Personality Trait in 150 participants. Completed in 31 March 2020.
31 March 2020
Quick facts
| Lead sponsor | University of Coimbra |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 1 March 2018 |
| Primary completion | 31 March 2020 |
| Estimated completion | 31 March 2020 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- PSYCHOPATHY.COMP program.
- Treatment As Usual - TAU
Conditions studied
- Psychopathic Personality Trait — all drugs for Psychopathic Personality Trait →
- Conduct Disorder — all drugs for Conduct Disorder →
- Delinquency — all drugs for Delinquency →
Sponsor
University of Coimbra
Who can join
Adults 14 to 18, male only, with Psychopathic Personality Trait or Conduct Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This non-randomized controlled trial with a control group aimed to assess the efficacy of a 20-session individualized Compassion Focused Therapy-based intervention, the PSYCHOPATHY.COMP, in reducing psychopathic traits (primary outcomes), aggression, shame, emotion regulation problems, and fears of compassion, as well as in increasing social safeness, self-compassion, and compassion towards others (secondary outcomes). The PSYCHOPATHY.COMP's impact on psychophysiological (i.e., Heart Rate/Heart Rate Variability) and behavioral indicators (i.e., number disciplinary infractions and number of days in punishment) were also tested, in order to ascertain if changes observed in self-report questionnaires were reflected in more adjusted psychophysiological and behavioral patterns. Mental Health disorders, as well as the number of Conduct Disorder criteria, were also tested as moderators of treatment effects.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
At the heart of change: Differences in young offenders' HRV patterns after the delivery of the PSYCHOPATHY.COMP program.
Sousa R, Ribeiro da Silva D, Petrocchi N, Gilbert P, et al · · 2022 · cited 2× · PMID 36704737 · DOI 10.3389/fpsyt.2022.1032011
Verify or expand the search:
- PubMed search for NCT03971682
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Psychopathic Personality Trait
Currently open trials in the same condition.
- NCT05802758 — CFT-focused Mental Health Intervention With Exposure Training for Youngsters · NA · recruiting
Other University of Coimbra trials
Trials by the same sponsor.
- NCT07018089 — The Efficacy of the iWork.COMP Among Health Care Professionals · NA · not yet recruiting
- NCT07481253 — PSYCHOPATHY.COMP Program Among Male Prison Inmates With Psychopathy · NA · not yet recruiting
- NCT07296081 — ⁶⁸Ga-FAPI PET/CT for Cardiac Fibrosis in Heart Failure · recruiting
- NCT07329647 — Targeting Neurovascular Coupling in Cognitive Decline Via Nitrate-Based Supplementation · NA · recruiting
- NCT06922071 — The REMINDER4Care Program for Older Adults Supported by Residential and Daycare Facilities · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03971682 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Coimbra
- Last refreshed: 27 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03971682.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing